-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803.O2.6 803. Emerging Diagnostic Tools and Techniques II

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
CRS, Anemias, sickle cell disease, Biological, Diseases, bioengineering, Lymphoma (any), sickle cell trait, platelets, CAR-Ts, Therapies, red blood cells, Pediatric, Adverse Events, white blood cells, Hemoglobinopathies, B-Cell Lymphoma, Biological Processes, Technology and Procedures, immune cells, Immune Disorders, T-Cell Lymphoma, cytogenetics, Cell Lineage, Study Population, Lymphoid Malignancies, Myeloid Malignancies, Clinically relevant, imaging, Quality Improvement , flow cytometry, immune mechanism, white blood cell disorders, molecular testing, newborn screening, NGS
Saturday, December 5, 2020: 12:00 PM-1:30 PM
Moderators:
Aziz Nazha, MD, and Manja Meggendorfer, PhD, MLL Munich Leukemia Laboratory
Disclosures:
Nazha: incyte: Speakers Bureau; novartis: Speakers Bureau; abbvie: Consultancy; Daiichi Sankyo: Consultancy.
12:00 PM

Christian Pohlkamp, MD1*, Kapil Jhalani1*, Niroshan Nadarajah1*, Inseok Heo, PhD2*, William Wetton2*, Rudolf Drescher, PhD3*, Siegfried Hänselmann, PhD3*, Thomas Lörch, PhD3*, Claudia Haferlach, MD1, Wolfgang Kern, MD1 and Torsten Haferlach, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2Amazon Web Services, Envision Engineering, Herndon
3MetaSystems, Altlussheim, Germany

12:15 PM

Ran An, PhD1, Yuncheng Man1*, Shamreen Iram1*, Erdem Kucukal, PhD1*, Muhammad Noman Hasan, PhD1*, Ambar Solis-Fuentes1*, Allison Bode1*, Ailis Hill1*, Kevin Cheng1*, Yuning Huang1*, Sanjay Ahuja, MD1,2, Jane A. Little, MD3, Michael Hinczewski, PhD1* and Umut A. Gurkan, PhD1

1Case Western Reserve University, Cleveland, OH
2University Hospitals Rainbow Babies & Children’s Hospital, Cleveland, OH
3University of North Carolina at Chapel Hill, Chapel Hill, NC

12:30 PM

Claudia Haferlach, MD1, Siegfried Hänselmann, PhD2*, Wencke Walter, PhD1*, Sarah Volkert1*, Melanie Zenger1*, Wolfgang Kern, MD1, Anna Stengel, PhD1, Thomas Lörch, PhD2* and Torsten Haferlach, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MetaSystems, Altlussheim, Germany

12:45 PM

Chiara Monfrini1*, Vanessa Aragona1*, Martina Magni2*, Riccardo Betta3*, Cristina Vella2*, Chiara Paolizzi2*, Anna Dodero4*, Annalisa Chiappella4, Anna Guidetti5, Paolo Corradini6 and Cristiana Carniti1*

1Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
3Fondazione IRCCS Istituto Nazionale Tumori and Università degli Studi di Milano, Milano, Italy
4Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
5Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori and Università degli Studi di Milano, Milano, Italy
6Fondazione IRCCS Istituto Nazionale dei Tumori and Università degli Studi di Milano, Milano, Italy

1:00 PM

Navika D Shukla1*, Alexander F. M. Craig, MPhil2, Brian Sworder, MD, PhD1, David M. Kurtz, MD, PhD1, Charles Macaulay, MSc, BA3*, Andrea Garofalo, BS, BA1*, Matthew J. Frank, MD, PhD4, Stefan Alig, MD1*, George Duran, BA5*, Youn H. Kim, MD6, James Zehnder, MD7, Crystal L. Mackall, MD8, David B. Miklos, MD, PhD4, Maximilian Diehn, MD, PhD9*, Michael S. Khodadoust, MD, PhD10 and Ash A. Alizadeh, MD, PhD11

1Department of Medicine, Divisions of Hematology & Oncology, Stanford University, Stanford, CA
2Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
3Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Palo Alto, CA
4Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
5Department of Medicine, Stanford University, Stanford
6Department of Dermatology, Stanford University School of Medicine, Stanford, CA
7Pathology and Medicine/Hematology, Stanford Univ. Med. Ctr., Stanford, CA
8Department of Pediatrics, Division of Hematology and Oncology, Stanford University, Stanford, CA
9Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA
10Department of Medicine, Division of Oncology & Department of Dermatology, Stanford University School of Medicine, Stanford, CA
11Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Stanford, CA

1:15 PM

Dongchu Wang1*, Xiang Li1*, Liyuan Qiu2*, Shizhe Fu1*, Lingyun Cui1*, Hui Wang, MD3* and Peihua Lu, MD4

1hebei yanda ludaopei hospital, Langfang, China
2Hebei Yanda Lu Daopei Hospital, langfang, China
3Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, langfang, China
4Hebei Yanda Lu Daopei Hospital, Langfang, China

*signifies non-member of ASH